BridgeMD
New treatment option for Hypertriglyceridemia
Official title Effect of Consuming n-3 Polyunsaturated Fatty Acids Rich Foods on Triglyceride Concentration and Lipoprotein Composition
ClinicalTrials.gov ID: NCT07004777
What this study is testing
- What it's testing
- Hypertriglyceridemia is one of the most prevalent lipid profile disorders and is linked to a large proportion of mortality in Mexico and around the world. Various international treatment guidelines for hypertriglyceridemia have suggested the consumption of foods rich in n-3 polyunsaturated fatty acids or their intake through supplementation as a complement to lifestyle changes.
- Time commitment: about 4 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Signing of the informed consent form
- Both sexes.
- Adults over 18 years of age.
- BMI \>18.5 kg/m2.
- Triglycerides between 200 and 500 mg/dL.
You likely can't join if
- Any type of diabetes.
- kidney disease diagnosed by a physician.
- Acquired diseases that secondarily cause obesity and diabetes.
- Patients who have suffered a cardiovascular event.
- Weight loss \>3 kg in the last 3 months.
- Catabolic diseases such as cancer and acquired immunodeficiency syndrome.
See the full eligibility criteria
- Signing of the informed consent form
- Both sexes.
- Adults over 18 years of age.
- BMI \>18.5 kg/m2.
- Triglycerides between 200 and 500 mg/dL.
- Total cholesterol less than 240 mg/dL
- Any type of diabetes.
- kidney disease diagnosed by a physician.
- Acquired diseases that secondarily cause obesity and diabetes.
- Patients who have suffered a cardiovascular event.
- Weight loss \>3 kg in the last 3 months.
- Catabolic diseases such as cancer and acquired immunodeficiency syndrome.
- Pregnancy.
- Treatment with any medication:
- Treatment with antihypertensive drugs (tricyclic, loop, or potassium-sparing diuretics, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers, alpha-blockers, calcium channel blockers...
- Treatment with hypoglycemic agents (sulfonylureas, biguanides, incretins) or - insulin and antidiabetics.
- Treatment with statins, fibrates, or other drugs to control dyslipidemia.
- Use of steroid medications, chemotherapy, immunosuppressants, or radiation therapy.
- Anorectic agents or those that accelerate weight loss.
- Treatment with any medication that influences inflammation (corticosteroids, nonsteroidal anti-inflammatory drugs, colchicine, interleukin-1 inhibitors) or triglyceride metabolism (metformin, glitazones, SGLT2...
- Anticoagulants and antiplatelets (warfarin, aspirin, clopidogrel).
- People with a smoking cessation index (SCI) greater than 21.
- People with a tobacco Index greater than 21.
- Consumption of large amounts of alcohol (14 drinks for women or 21 drinks for men in a typical week).
- Consumption of any recreational psychoactive substance.
- Allergy or intolerance to any food listed in the proposed pantry.
- Unwillingness to consume any of the foods listed in the proposed pantry.
- Previous n-3 PUFA supplementation.
The study team makes the final eligibility decision.
Where it's taking place
- Mexico City, Mexico City, Mexico
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 4 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Mexico City, Mexico City, Mexico. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.